COST

988.86

+1.32%↑

PG

158.62

+1.16%↑

MO

65.37

+0.32%↑

CL

94.74

+0.46%↑

SYY

84.6

+0.02%↑

COST

988.86

+1.32%↑

PG

158.62

+1.16%↑

MO

65.37

+0.32%↑

CL

94.74

+0.46%↑

SYY

84.6

+0.02%↑

COST

988.86

+1.32%↑

PG

158.62

+1.16%↑

MO

65.37

+0.32%↑

CL

94.74

+0.46%↑

SYY

84.6

+0.02%↑

COST

988.86

+1.32%↑

PG

158.62

+1.16%↑

MO

65.37

+0.32%↑

CL

94.74

+0.46%↑

SYY

84.6

+0.02%↑

COST

988.86

+1.32%↑

PG

158.62

+1.16%↑

MO

65.37

+0.32%↑

CL

94.74

+0.46%↑

SYY

84.6

+0.02%↑

Search

USANA Health Sciences Inc

Uždarymo kaina

20.66 -0.96

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.13

Max

20.78

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-17M

-6.7M

Pardavimai

-22M

214M

P/E

Sektoriaus vid.

24.067

29.995

Pelnas, tenkantis vienai akcijai

-0.15

Pelno marža

-3.118

Darbuotojai

1,700

EBITDA

-17M

11M

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-17

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

14M

396M

Ankstesnė atidarymo kaina

21.62

Ankstesnė uždarymo kaina

20.66

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-05 23:57; UTC

Uždarbis

Naver Has Record Year Despite Weaker Final Quarter

2026-02-05 23:45; UTC

Karštos akcijos

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

2026-02-05 22:26; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

2026-02-05 22:00; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

2026-02-05 23:47; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-02-05 23:47; UTC

Rinkos pokalbiai

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

2026-02-05 23:43; UTC

Rinkos pokalbiai

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

2026-02-05 23:37; UTC

Rinkos pokalbiai

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

2026-02-05 23:20; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

2026-02-05 23:11; UTC

Rinkos pokalbiai

Amazon CEO Confident in Return on $200B Investment -- Market Talk

2026-02-05 23:09; UTC

Uždarbis

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

2026-02-05 23:08; UTC

Uždarbis

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

2026-02-05 23:07; UTC

Uždarbis

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

2026-02-05 23:03; UTC

Rinkos pokalbiai
Uždarbis

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

2026-02-05 23:03; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

2026-02-05 23:00; UTC

Uždarbis

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

2026-02-05 23:00; UTC

Uždarbis

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

2026-02-05 22:59; UTC

Uždarbis

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

2026-02-05 22:59; UTC

Uždarbis

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

2026-02-05 22:52; UTC

Uždarbis

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

2026-02-05 22:45; UTC

Uždarbis

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

2026-02-05 22:37; UTC

Rinkos pokalbiai

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

2026-02-05 22:11; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

2026-02-05 22:03; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

2026-02-05 22:01; UTC

Uždarbis

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

2026-02-05 21:59; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

2026-02-05 21:51; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

2026-02-05 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Basic Materials Roundup: Market Talk

2026-02-05 21:49; UTC

Uždarbis

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

2026-02-05 21:45; UTC

Uždarbis

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat